Navigation Links
Greenwood Genetic Center Selects Cartagenia BENCHlab NGS, CNV Solutions for Clinical Data Analysis

BOSTON and GREENWOOD, S.C., March 19, 2013 /PRNewswire/ -- Cartagenia, the world leader in providing genetic labs and clinicians software-based workflow support for variant assessment, lab reporting, and integration of diagnostic knowledge-bases, announced today that it has signed a license agreement for its BENCHlab NGS and CNV solutions with South Carolina-based Greenwood Genetic Center, a non-profit institute that provides clinical genetic services and diagnostic laboratory testing.

Cartagenia's NGS product is tailored to support the adoption of Next Generation Sequencing technology in clinical practice and focuses on standardizing the data interpretation process. The NGS product was created to handle such data as gene panels, exomes and whole genomes and to automatically generate clinical reports specific to Greenwood's needs.

After developing the product and using it extensively in Europe, Greenwood is the first US customer to license the NGS product.

The Cartagenia BENCHlab CNV solution is a product that helps labs deploy microarray testing for prenatal diagnosis, as well as a seamless transition from prenatal to continued post-natal follow-up.

"We generate DNA sequencing data on large portions of the genome and Cartagenia's products facilitate the sorting, filtering and organization of these data and ultimately aid in the process of interpreting the genetic alterations," said Mike Friez , Greenwood's Director of Diagnostic Laboratories, adding that while most of Greenwood's clinical samples originate in South Carolina, they also receive samples from around the country and even internationally. "The amount of raw information produced by these types of tests creates a complex data management and reporting challenge. While such new technologies may be very effective at helping us to determine the underlying genetic alterations, we generate reams of data that we need to manage, understand and translate for the benefit of the patients and their families."

Cartagenia's BENCHlab NGS solution was designed to support the four essential steps in robust and reliable NGS data analysis: To store and annotate genomic variants and patient information, explore and identify disease mutations, validate clinical findings and interpretation workflows and automate lab reporting.

BENCHlab CNV helps laboratories perform fast and accurate variant assessment by providing extensive, integrated reference data and automated searching against lab-managed CNV sets and public databases of known aberrations. It was developed to be a powerful reporting engine that drafts comprehensive, high-quality lab reports with minimal effort, noted Cartagenia CEO Herman Verrelst .

"We designed our BENCHlab products to be straightforward and user-friendly," Verrelst said. "Our goal is to make diagnostic laboratory testing a routine part of a lab's practice with a system optimized exactly for a lab like Greenwood's needs."

Cartagenia products are HIPAA compliant and ISO13485 certified.

About Greenwood Genetic Center
Greenwood Genetic Center is a nonprofit organization advancing the field of medical genetics and caring for families impacted by genetic disease and birth defects. Its mission is to provide clinical genetic services, diagnostic laboratory testing, educational programs and resources and research in the field of medical genetics. Based in Greenwood, SC, with satellite offices in Charleston, Columbia, Florence and Greenville, GGC extends its reach to all residents of South Carolina. For more information, visit

About Cartagenia
Cartagenia supplies diagnostic software, database systems, and related services to genetic labs and clinicians, enabling them to perform clinically relevant genetic analyses quickly and efficiently, and offer patients and careers high-quality genetic interpretation and counseling.

The Cartagenia BENCH platform is built in collaboration with genetics labs and clinical experts involved in routine medical  practice. Because of this, BENCHlab CNV addresses the specific needs of genetic diagnostic labs and clinicians.

Cartagenia BENCHlab CNV is built using a certified ISO13485 Quality Management System and is marketed as an FDA regulated Class I Medical Device in the United States and as a Class I Medical Device in Europe in conformity with the essential requirements and provisions of the Council Directive 93/42/EEC concerning medical devices, and with the relevant harmonized standards EN ISO62304.

Herman Verrelst
CEO Cartagenia
Technologielaan 3
3001 Leuven
T +32 16 40 40 66

Len Hall
VP Media Relations
T 1 949 474 4300

SOURCE Cartagenia
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Interleukin Genetics Reports Third Quarter 2011 Financial Results
2. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
3. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
4. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
5. Cytogenetics - Technologies, Markets and Companies
6. 23andMe Presents Top Ten Most Interesting Genetic Findings of 2011
7. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
8. deCODE Genetics, in Collaboration with Academic Colleagues, Discovers Three Variants in the Sequence of the Human Genome that Affect the Risk of Thyroid Cancer
9. GeneThera, Inc. Acquires Applied Genetics, S.A.
10. Genetics Policy Institute (GPI) Files Additional Legal Arguments in Sherley v. Sebelius Stem Cell Case
11. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Post Your Comments:
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
(Date:11/24/2015)... ... 24, 2015 , ... The Academy of Model Aeronautics (AMA), led by its ... as Multirotor Grand Prix, to represent the First–Person View (FPV) racing community. , FPV ... embraced this type of racing and several new model aviation pilots have joined the ...
(Date:11/24/2015)... --> --> ... by Transparency Market Research, the global non-invasive prenatal testing ... 17.5% during the period between 2014 and 2022. The ... Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 ... to reach a valuation of US$2.38 bn by 2022. ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - ... "Company") announced today that the remaining 11,000 post-share ... Share Purchase Warrants (the "Series B Warrants") subject ... were exercised on November 23, 2015, which will ... Shares.  After giving effect to the issuance of ...
Breaking Biology Technology:
(Date:10/29/2015)...  Connected health pioneer, Joseph C. Kvedar , ... health and wellness, and the business opportunities that arise ... Internet of Healthy Things . Long before health ... Dr. Kvedar, vice president, Connected Health, Partners HealthCare, was ... care from the hospital or doctor,s office into the ...
(Date:10/27/2015)... -- Munich, Germany , October ... automatically maps data from mobile eye tracking videos created ... that they can be quantitatively analyzed with SMI,s analysis ... , October 28-29, 2015. SMI,s Automated Semantic Gaze ... tracking videos created with SMI,s Eye Tracking Glasses ...
(Date:10/26/2015)... NEWARK, Calif. , Oct. 26, 2015  Delta ... convenient biometric authentication to mobile and PC devices, announced ... Fujitsu,s smartphone, the arrows NX F-02H launched by NTT ... arrows NX F-02H is the second smartphone to include ... this technology in ARROWS NX F-04G in May 2015, ...
Breaking Biology News(10 mins):